The intestinal mucosa maintains its integrity through spatiotemporal regulation of proliferation, differentiation, migration, and cell death along the crypt-luminal axis of the intestine. The molecular mechanisms that coordinate these events, particularly in the context of injury repair, are not well understood. Furthermore, it is not known how perturbations of these processes impact cell junction formation and barrier function. Kruppel- like factor 5 (KLF5) is a member of a family of transcription factors that function in the regulation of diverse cellular processes including development, proliferation, and differentiation. KLF5 is highly expressed in the proliferative component of the intestinal epithelium, and has been shown to promote proliferation of intestinal epithelial cells in vitro and in vivo. Recent dat from mice with intestine-specific deletion of Klf5 indicate that KLF5 is required for maintenance of intestinal crypt architecture and epithelial barrier integrity. In addition, it was shown recenty that KLF5 is necessary for mucosal healing in the dextran sulfate sodium (DSS) mouse model of colitis. Based on these results, we hypothesize that KLF5 controls renewal and maturation of epithelial cells along the crypt-luminal axis and is required for intestinal epithelial integrity. he following aims have been developed to test this hypothesis: (I) Define the role of KLF5 in regulating proliferation, migration, and maturation of epithelial cells along the crypt-luminal axi of the intestine. Genetic mouse models and cell culture systems will be used for ectopic expression or inhibition of KLF5 to explore the role of KLF5 in regulating processes involved in intestinal epithelial homeostasis. (II) Determine the requirement of KLF5 in maintaining intestinal epithelial barrier function. The effects of KLF5 expression on intestinal permeability and the formation of apical junctional complexes will be determined. (III) Examine the role of KLF5 in intestinal epithelial wound repair. These experiments will test whether increased levels of KLF5 can improve outcome and epithelial healing in DSS-induced colitis. Several methods to increase KLF5 expression in the mouse colon will be tested, including adenoviral delivery, nanoparticle delivery and transgenic expression. Reciprocal studies using mice with inducible intestine-specific deletion of Klf5 will also be conducted to test whether KLF5 is necessary for repair of intestinal injury. The long-term goal of these studies is to elucidate the molecular mechanisms that regulate intestinal epithelial integrity, both in situations of tissue renewal and injury repar. The proposed studies will contribute to a better understanding of factors that coordinate the processes of proliferation, migration, and differentiation to maintain intestinal architecture and barrier function. In particular, these studies will explore novel roles for KLF5 in the processes o epithelial maturation, migration, and cell junction formation, and the possibility for KLF5 as a therapeutic target in disease conditions such as inflammatory bowel disease.
One of the major complications and possibly causes of inflammatory bowel disease (IBD) is disruption of the barrier function of the intestinal epithelium which exacerbates and prolongs active flare-ups. Understanding how the injured mucosa is repaired and identifying key molecules involved in the maintenance and repair of the epithelial barrier function can provide potential therapeutic targets directed at mucosal healing in IBD patients.
|He, Ping; Yang, Jong Won; Yang, Vincent W et al. (2017) Krüppel-like Factor 5, Increased in Pancreatic Ductal Adenocarcinoma, Promotes Proliferation, Acinar to Ductal Metaplasia, Pancreatic Intraepithelial Neoplasia, and Tumor Growth in Mice. Gastroenterology :|
|Ghaleb, Amr M; Yang, Vincent W (2017) Krüppel-like factor 4 (KLF4): What we currently know. Gene 611:27-37|
|Kim, Chang-Kyung; Bialkowska, Agnieszka B; Yang, Vincent W (2016) Intestinal stem cell resurgence by enterocyte precursors. Stem Cell Investig 3:49|
|Ghaleb, Amr M; Elkarim, Enas A; Bialkowska, Agnieszka B et al. (2016) KLF4 Suppresses Tumor Formation in Genetic and Pharmacological Mouse Models of Colonic Tumorigenesis. Mol Cancer Res 14:385-96|
|Nandan, Mandayam O; Ghaleb, Amr M; Bialkowska, Agnieszka B et al. (2015) Krüppel-like factor 5 is essential for proliferation and survival of mouse intestinal epithelial stem cells. Stem Cell Res 14:10-9|
|Kuruvilla, Jes G; Ghaleb, Amr M; Bialkowska, Agnieszka B et al. (2015) Role of Krüppel-like factor 5 in the maintenance of the stem cell niche in the intestinal crypt. Stem Cell Transl Investig 2:|
|Ghaleb, Amr M; Bialkowska, Agnieszka B; Snider, Ashley J et al. (2015) IQ Motif-Containing GTPase-Activating Protein 2 (IQGAP2) Is a Novel Regulator of Colonic Inflammation in Mice. PLoS One 10:e0129314|
|Nandan, Mandayam O; Ghaleb, Amr M; Liu, Yang et al. (2014) Inducible intestine-specific deletion of Krüppel-like factor 5 is characterized by a regenerative response in adult mouse colon. Dev Biol 387:191-202|
|Ghaleb, Amr M; Laroui, Hamed; Merlin, Didier et al. (2014) Genetic deletion of Klf4 in the mouse intestinal epithelium ameliorates dextran sodium sulfate-induced colitis by modulating the NF-?B pathway inflammatory response. Inflamm Bowel Dis 20:811-20|
|Bialkowska, Agnieszka B; Liu, Yang; Nandan, Mandayam O et al. (2014) A colon cancer-derived mutant of Krüppel-like factor 5 (KLF5) is resistant to degradation by glycogen synthase kinase 3? (GSK3?) and the E3 ubiquitin ligase F-box and WD repeat domain-containing 7? (FBW7?). J Biol Chem 289:5997-6005|
Showing the most recent 10 out of 11 publications